Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 5382

BillFederalHouseIn Committee
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
About This Bill
Committee
Latest Action · December 11, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
December 10, 2019
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.